Healthcare In China - 0 views
-
Bharatbookbureau MarketReport on 06 Jul 12In 2009, China's government announced plans to invest RMB1.13 trillion ($180 billion) in expanding and improving healthcare provision, through significant healthcare reforms. This massive spending program is rapidly expanding healthcare access for China's 1.3 billion citizens, and has implications for the pharmaceutical industry worldwide. Inside China's Healthcare Reforms: Opportunities for Multinational pharma This comprehensive report goes deep inside China to reveal the ways that recent reforms are changing healthcare for rural and urban citizens. Numerous local experts have been consulted for their insights, including industry experts, government officials, ministry advisers, and formulary managers. The reader-friendly report explores each key aspect of healthcare reform in turn, clearly explaining what it is, why it was needed, and what progress has been made so far, and then summarising its specific implications for the pharma industry. As well as covering recent reforms, the report also examines key reform priorities through to 2015.